doi: 10.1016/s0022-5347(17)56539-8.
Experience with flutamide in previously untreated patients with advanced prostatic cancer
- PMID: 501817
- DOI: 10.1016/s0022-5347(17)56539-8
Item in Clipboard
Experience with flutamide in previously untreated patients with advanced prostatic cancer
J Urol.
1979 Nov.
Abstract
Twenty-one patients with advanced prostatic adenocarcinoma previously untreated with conventional endocrine therapy were treated with an oral non-steroidal antiandrogen, flutamide. There were 19 favorable responders, 1 failure and 1 equivocal response. Flutamide seems to be a safe antiandrogen, which is effective in the management of previously untreated patients with advanced prostatic carcinoma.
Similar articles
-
Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.Cancer. 1984 Aug 15;54(4):744-50. doi: 10.1002/1097-0142(1984)54:4<744::aid-cncr2820540426>3.0.co;2-p. Cancer. 1984. PMID: 6378356 Clinical Trial.
-
Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment.Urology. 1975 Aug;6(2):164-6. doi: 10.1016/0090-4295(75)90704-9. Urology. 1975. PMID: 1145932
-
Flutamide therapy for advanced prostatic cancer: a phase II study.Br J Urol. 1985 Apr;57(2):172-4. doi: 10.1111/j.1464-410x.1985.tb06415.x. Br J Urol. 1985. PMID: 3986452
-
Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.Cancer Treat Res. 1988;39:131-45. doi: 10.1007/978-1-4613-1731-9_9. Cancer Treat Res. 1988. PMID: 2908604 Review.
-
[Antiandrogen in prostate cancer].Nihon Rinsho. 2002 Dec;60 Suppl 11:188-92. Nihon Rinsho. 2002. PMID: 12599569 Review. Japanese. No abstract available.
Cited by
-
The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment.Eur J Clin Pharmacol. 1988;34(6):633-6. doi: 10.1007/BF00615229. Eur J Clin Pharmacol. 1988. PMID: 3169114
-
Antiandrogens in prostate cancer.Invest New Drugs. 1999;17(3):271-84. doi: 10.1023/a:1006344807086. Invest New Drugs. 1999. PMID: 10665479 Review.
-
Temporary prostatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention.J R Soc Med. 1993 Nov;86(11):634-6. doi: 10.1177/014107689308601107. J R Soc Med. 1993. PMID: 8258796 Free PMC article.
-
Update in cancer chemotherapy: genitourinary tract cancer, Part 3: Cancer of the prostate.J Natl Med Assoc. 1988 Mar;80(3):305-14. J Natl Med Assoc. 1988. PMID: 3280813 Free PMC article. Review.
-
Advances in the treatment of metastatic prostatic cancer.West J Med. 1985 Sep;143(3):342-5. West J Med. 1985. PMID: 2413632 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources